Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

5-MeO-NiPT

From Wikipedia, the free encyclopedia
Pharmaceutical compound
5-MeO-NiPT
Clinical data
Other names5-Methoxy-N-isopropyltryptamine
Drug classSerotonin receptor agonist;Serotonin 5-HT2A receptor agonist;Serotonergic psychedelic;Hallucinogen
ATC code
  • None
Identifiers
  • N-[2-(5-methoxy-1H-indol-3-yl)ethyl]propan-2-amine
CAS Number
PubChemCID
ChemSpider
UNII
CompTox Dashboard(EPA)
Chemical and physical data
FormulaC14H20N2O
Molar mass232.327 g·mol−1
3D model (JSmol)
  • COc1ccc2c(c1)c(CCNC(C)C)c[nH]2
  • InChI=1S/C14H20N2O/c1-10(2)15-7-6-11-9-16-14-5-4-12(17-3)8-13(11)14/h4-5,8-10,15-16H,6-7H2,1-3H3
  • Key:QQZJNZJNPDORBO-UHFFFAOYSA-N

5-MeO-NiPT, also known as5-methoxy-N-isopropyltryptamine, is apsychedelic drug of thetryptamine family related to5-MeO-DMT.[1][2][3]

The drug acts as anon-selectiveserotonin receptor agonist, including of theserotonin5-HT2A receptor.[1][2][3]

5-MeO-NiPT was encountered as a noveldesigner andrecreational drug by 2014.[2][4]

Use and effects

[edit]

5-MeO-NiPT was not included nor mentioned inAlexander Shulgin's bookTiHKAL (Tryptamines I Have Known and Loved).[5]

Interactions

[edit]
See also:Psychedelic drug § Interactions, andTrip killer § Serotonergic psychedelic antidotes

Pharmacology

[edit]

Pharmacodynamics

[edit]

5-MeO-NiPT is afull agonist or near-full agonist of theserotonin5-HT1A,5-HT2A,5-HT2B, and5-HT2C receptors.[1][2][3] It is inactive as aserotonin releasing agent and is very weak as aserotonin reuptake inhibitor.[2][3]

Unlike most otherN-monoalkylated tryptamines, 5-MeO-NiPT produces thehead-twitch response (HTR), a behavioral proxy ofpsychedelic effects, in rodents, albeit relatively weakly.[1][2] It also produceshypolocomotion andhypothermia in rodents.[1][2] In combination with the serotonin 5-HT1A receptorantagonistWAY-100635 however, 5-MeO-NiPT instead produceshyperlocomotion.[1]

5-MeO-NiPT is anactive metabolite of5-MeO-MiPT and5-MeO-DiPT.[1][6]

Chemistry

[edit]

Analogues

[edit]

Analogues of 5-MeO-NiPT includeN-isopropyltryptamine (NiPT),5-MeO-NMT,5-MeO-NET,5-MeO-DiPT, and5-MeO-MiPT, among others.[5]

Society and culture

[edit]

Legal status

[edit]

Canada

[edit]

5-MeO-NiPT is not acontrolled substance inCanada.[7]

Sweden

[edit]

5-MeO-NiPT is acontrolled substance inSweden.[8]

United States

[edit]

5-MeO-NiPT is not an explicitlycontrolled substance in theUnited States.[9] However, it could be considered acontrolled substance under theFederal Analogue Act if intended for human consumption.

See also

[edit]

References

[edit]
  1. ^abcdefgGlatfelter GC, Clark AA, Cavalco NG, Landavazo A, Partilla JS, Naeem M, Golen JA, Chadeayne AR, Manke DR, Blough BE, McCorvy JD, Baumann MH (December 2024). "Serotonin 1A Receptors Modulate Serotonin 2A Receptor-Mediated Behavioral Effects of 5-Methoxy-N,N-dimethyltryptamine Analogs in Mice".ACS Chem Neurosci.15 (24):4458–4477.doi:10.1021/acschemneuro.4c00513.PMID 39636099.
  2. ^abcdefgPuigseslloses P, Nadal-Gratacós N, Ketsela G, Weiss N, Berzosa X, Estrada-Tejedor R, Islam MN, Holy M, Niello M, Pubill D, Camarasa J, Escubedo E, Sitte HH, López-Arnau R (August 2024)."Structure-activity relationships of serotonergic 5-MeO-DMT derivatives: insights into psychoactive and thermoregulatory properties".Mol Psychiatry.29 (8):2346–2358.doi:10.1038/s41380-024-02506-8.PMC 11412900.PMID 38486047.
  3. ^abcdBlough BE, Landavazo A, Decker AM, Partilla JS, Baumann MH, Rothman RB (October 2014)."Interaction of psychoactive tryptamines with biogenic amine transporters and serotonin receptor subtypes".Psychopharmacology (Berl).231 (21):4135–4144.doi:10.1007/s00213-014-3557-7.PMC 4194234.PMID 24800892.
  4. ^EMCDDA–Europol 2014 annual report on the implementation of Council Decision 2005/387/JHA. Publications Office of the European Union. 3 July 2015.ISBN 978-92-9168-821-0. Retrieved2 March 2025.
  5. ^abShulgin, Alexander;Shulgin, Ann (September 1997).TiHKAL: The Continuation.Berkeley, California:Transform Press.ISBN 0-9630096-9-9.OCLC 38503252.
  6. ^Araújo AM, Carvalho F, Bastos ML, Guedes de Pinho P, Carvalho M (2015)."The hallucinogenic world of tryptamines: an updated review"(PDF).Archives of Toxicology.89 (8):1151–1173.Bibcode:2015ArTox..89.1151A.doi:10.1007/s00204-015-1513-x.ISSN 0340-5761.PMID 25877327.
  7. ^"Controlled Drugs and Substances Act".Department of Justice Canada. 5 December 2025. Retrieved20 January 2026.
  8. ^"5-MeO-NIPT".АИПСИН (in Russian). Retrieved6 January 2026.
  9. ^Orange Book: List of Controlled Substances and Regulated Chemicals (January 2026)(PDF),United States: U.S.Department of Justice:Drug Enforcement Administration (DEA): Diversion Control Division, January 2026

External links

[edit]
Tryptamines
No ring subs.
4-Hydroxytryptamines
5-Hydroxytryptamines
5-Methoxytryptamines
Other ring subs.
α-Alkyltryptamines
Others
Cyclized
Bioisosteres
Phenethylamines
Scalines
2C-x
3C-x
DOx
4C-x
Ψ-PEA
MDxx
FLY
25x-NB (NBOMes)
Others
Cyclized
Lysergamides
Others
Natural sources
5-HT1
5-HT1A
5-HT1B
5-HT1D
5-HT1E
5-HT1F
5-HT2
5-HT2A
5-HT2B
5-HT2C
5-HT37
5-HT3
5-HT4
5-HT5A
5-HT6
5-HT7
Tryptamines
4-Hydroxytryptamines
andesters/ethers
5-Hydroxy- and
5-methoxytryptamines
N-Acetyltryptamines
α-Alkyltryptamines
α-Ketotryptamines
Cyclized tryptamines
Isotryptamines
Related compounds
Retrieved from "https://en.wikipedia.org/w/index.php?title=5-MeO-NiPT&oldid=1338238601"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2026 Movatter.jp